相关实验视频

Updated: Feb 4, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

术前栓塞用于体和体下瘤

Satoshi Koizumi¹, Shigeta Fujitani¹, Takeru Hirata¹

¹Department of Neurosurgery, The University of Tokyo, Tokyo, Japan.

Journal of neuroendovascular therapy

|February 3, 2026

概括

手术前瘤栓塞是骨底部手术的安全有效补充. 这种技术减少了瘤血管和亡,帮助复杂的切除,并发症最小.

科学领域:

神经外科神经外科
干预性放射学干预性放射学
血管神经学血管神经学

背景情况:

体和体下瘤由于深部位置和复杂的血管性,造成了外科手术的挑战.
术前栓塞是改善这些瘤手术结果的潜在补充.
有限的数据存在于手术前栓塞的安全性和有效性,用于体瘤.

研究的目的:

审查术前栓塞治疗瘤的技术考虑和结果.
在一系列患者中评估该程序的安全性和有效性.
详细说明栓塞技术和料容器类别.

主要方法:

对29次连续的术前栓塞手术进行腔瘤的回顾性审查.
针对中间 (MHT,ILT),侧面 (中脑膜动脉,尾动脉) 和下部 (APA) 食器的技术方法的分析.
评估技术成功,使用的栓塞剂和栓塞后并发症.

主要成果:

技术成功率为96.6% (28/29程序).
主要来自MHT/ILT (53.6%) 和APA (21.4%) 的栓塞;多种食者在46.6%的目标.
主要的栓塞剂:N-丁烯酸 (85.7%),线圈 (39.3%),颗粒 (35.7%).
7.1% (2/29例) 的神经并发症,主要是脑神经.
在60.7%的患者中实现了瘤缩,在10.7%的患者中完全消失了对比度增强剂.

结论:

术前栓塞瘤是可行的和有效的.
该程序为随后的手术切除提供了实质性的好处,当使用专业知识进行时.
在复杂的骨底部手术中,这种技术存在可接受的风险.

关键词:

上升的喉动脉.血栓塞栓化血栓塞栓化是一个过程.脑膜低细胞体干中间脑膜关动脉状瘤是一种状瘤.

更多相关视频

Induction of Cerebral Arterial Gas Embolism in Rat

Induction of Cerebral Arterial Gas Embolism in Rat

Published on: October 18, 2024

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

相关概念视频

Pulmonary Embolism I: Introduction

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...

Pulmonary Embolism III: Nursing Management

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...